Pricing Log in Create free account

Cardio Diagnostics Holdings, Inc. (CDIO) vs Senti Biosciences, Inc. (SNTI)

Cardio Diagnostics Holdings, Inc. and Senti Biosciences, Inc. are both Biotechnology companies. Cardio Diagnostics Holdings, Inc. and Senti Biosciences, Inc. are of similar size ($5.1M and $5.0M). Cardio Diagnostics Holdings, Inc. grew revenue faster over the last twelve months: −3.23% against −70.7%. Senti Biosciences, Inc. has the higher net margin (−3,789.3% vs −42,429.2%) and the higher return on invested capital (0.00% vs −228.0%). Across the 14 metrics below, Senti Biosciences, Inc. leads on 8 and Cardio Diagnostics Holdings, Inc. on 6.

Valuation

Metric CDIO SNTI Biotechnology median
P/E n/m n/m 10.60
P/S 319.37 3.81 9.40
P/B 0.85 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.03 0.66
EV/Sales 61.50 (1.10) 9.02
Earnings yield (176.97%) (1,106.25%) (32.88%)
Free cash flow yield (121.78%) (761.30%) (23.13%)

Profitability

Metric CDIO SNTI Biotechnology median
Gross margin 100.00% 100.00% 68.51%
Operating margin (42,356.17%) (4,181.12%) 0.00%
Net margin (42,429.24%) (3,789.30%) 0.00%
Free cash flow margin (37,817.51%) (2,900.38%) 0.00%
Return on equity (93.55%) (466.46%) (51.96%)
Return on assets (87.24%) (97.52%) (46.06%)
Return on invested capital (227.98%) 0.00% 0.00%

Growth

Metric CDIO SNTI Biotechnology median
Revenue growth (TTM) (3.23%) (70.73%) 6.76%
EPS growth (last fiscal year) 60.15% 77.31% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — — 0.00%

Health

Metric CDIO SNTI Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 17.44 0.83 4.97
Net debt to EBITDA 0.84 0.25 1.01

Dividend

Metric CDIO SNTI Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CDIO SNTI Biotechnology median
Market cap 4.96m 5.12m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack